comparemela.com

Latest Breaking News On - Zimmer development agreement - Page 2 : comparemela.com

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results

/PRNewswire/ NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technology company focused on improving.

Zimmer biometDave rosaExchange commissionNeuroone medical technologies corporationZimmer development agreementSecurities exchangeNeuroone medical technologies corporation nasdaqAnnual reportFull year fiscalOne medical technologies corporationSecurities actSecurities exchange act

NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

/PRNewswire/ NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving.

Zimmer biometDave rosaExchange commissionCompany evoNeuroone medical technologies corporationZimmer development agreementPrnewswire neuroone medical technologies corporationSecurities exchangeOne medical technologies corporationRecent businessBiennial meetingWorld societyFunctional neurosurgerySouth koreaseptemberUpcoming targetedThird quarter

NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

/PRNewswire/ NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving.

Zimmer biometDave rosaExchange commissionCompany evoNeuroone medical technologies corporationZimmer development agreementPrnewswire neuroone medical technologies corporationSecurities exchangeOne medical technologies corporationRecent businessBiennial meetingWorld societyFunctional neurosurgerySouth koreaseptemberUpcoming targetedThird quarter

NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

/PRNewswire/ NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving.

United statesZimmer biometDave rosaMaria vomeroNeuroone evoNeuroone medical technologies corporationZimmer development agreementFox business networkUniversity of minnesota neuromodulation symposiumExchange commissionSecurities exchangePrnewswire neuroone medical technologies corporationGordon research conferenceOne medical technologies corporationRecent businessEvo cortical

NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

/PRNewswire/ NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving.

United statesZimmer biometDave rosaMaria vomeroNeuroone evoNeuroone medical technologies corporationZimmer development agreementFox business networkUniversity of minnesota neuromodulation symposiumExchange commissionSecurities exchangePrnewswire neuroone medical technologies corporationGordon research conferenceOne medical technologies corporationRecent businessEvo cortical

vimarsana © 2020. All Rights Reserved.